|Mr. Carlos Jose Gil||CEO, Pres, Chief Accounting & Financial Officer, Treasurer, Sec. and Sole Director||62.7k||N/A||1971|
Zenosense, Inc., through its joint venture, MIDS Medical Ltd., operates as a healthcare technology company. It develops MIDS Cardiac, a hand-held point of care cardiac diagnostic device targeting cardiac markers for the diagnosis of heart attack and cardiac related illnesses. The company was formerly known as Braeden Valley Mines, Inc. and changed its name to Zenosense, Inc. in November 2013. Zenosense, Inc. was founded in 2008 and is headquartered in Valencia, Spain.
Zenosense, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.